Retrospective Data Analysis of Patients With Metastatic Lung Adenocarcinoma With or Without KRAS -Mutation or TTF1 -Expression.

Miriam MoellerFlorian SchaedlichWolfgang Schuette

Published in: Cancer control : journal of the Moffitt Cancer Center (2022)

mutation and the change from a regimen containing pemetrexed to a regimen containing no pemetrexed, the corresponding patients no longer seem to have a worse prognosis.

Keyphrases

data analysis
small cell lung cancer
end stage renal disease
ejection fraction
chronic kidney disease
advanced non small cell lung cancer
poor prognosis
peritoneal dialysis
prognostic factors
cross sectional
patient reported outcomes
long non coding rna
tyrosine kinase
patient reported
wild type